PREVALENCE OF CLINICAL DISEASES AND DISORDERS OF CATTLE AND GOAT AT UPAZILA VETERINARY HOSPITAL, SHERPUR SADAR, SHERPUR

Abstract

At the Upazila Veterinary Hospital (UVH), Sherpur Sadar, in the Sherpur district, research was done from February to April 2022 to compare the clinical prevalence of various diseases and disorders in cattle and goats. Total animals were 235, among them cattle were 110 and goats were 125. Diagnosis was done based on general examination, physical examination, and clinical examination. Clinical examinations detected 18 different types of diseases and disorders in 110 cattle. Among the cases, Gastrointestinal problems 43 (19.2%), Musculoskeletal problems 32 (29.1%), Urogenital problems 18 (16.4%), Integumentary problems 17 (15.4%) were recorded in cattle. Age wise prevalence in young and adult cattle were 29 (26.4%) and 81 (73.6%) respectively. Sex wise prevalence in male and female cattle were 37 (33.6%) and 73 (66.4%) respectively. In case of goats 14 different diseases and disorders were recorded in 125 goats. Among the cases, Gastrointestinal problems 40 (28%), Musculoskeletal problems 18 (14.4%), Integumentary problems 18(12.8%), Urogenital problems 22 (17.6%), Respiratory problems 30 (24%), Sense organ problems 1 (0.8%), Circulatory problems 3 (2.4%) were recorded. Age wise prevalence in young and adult goats were 29 (26.4%) and 81 (73.6%) respectively. Sex wise prevalence in male and female goats were 37 (33.6%) and 73 (66.4%) respectively. There are diseases and disorders in cattle and goats that affect both juvenile and adult animals, however some of the specific diseases and disorders only affect older animals because they are more vulnerable to them. The study found that ruminants (cattle and goats) are more prone to gastrointestinal issues, musculoskeletal issues, and urogenital issues. For veterinarians, researchers, and policymakers to take the required actions to reduce the incidence of clinical diseases in goats and cattle, it will be helpful to identify and analyze the trend of clinical diseases that are present in the study region.